Merrimack Pharmaceuticals, Inc. (MACK)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
28-Dec-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 28-Dec-23Purchase 857$13.35$11,441.20< 1%
533.15K to 534.01K
28-Dec-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 26-Dec-23Purchase 48,693$13.15$640,313.0010%
484.46K to 533.15K
11-Dec-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 07-Dec-23Purchase 101,050$12.85$1,298,470.005%
2.12M to 2.22M
20-Nov-23 10:00 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 17-Nov-23Purchase 300$12.50$3,750.00< 1%
2.12M to 2.12M
16-Nov-23 5:09 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 14-Nov-23Purchase 50,170$12.50$627,125.002%
2.07M to 2.12M
14-Nov-23 10:00 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 13-Nov-23Purchase 15,570$12.39$192,875.00< 1%
2.05M to 2.07M
14-Nov-23 10:00 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 10-Nov-23Purchase 38,062$12.32$469,008.002%
2.01M to 2.05M
13-Nov-23 10:00 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 09-Nov-23Purchase 9,975$12.19$121,618.00< 1%
2.0M to 2.01M
13-Nov-23 10:00 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 08-Nov-23Purchase 13,823$12.13$167,701.00< 1%
1.99M to 2.0M
14-Aug-23 4:06 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 11-Aug-23Purchase 2,000$12.43$24,865.202%
131.1K to 133.1K
14-Aug-23 4:06 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 10-Aug-23Purchase 2,000$12.52$25,039.202%
131.1K to 133.1K
09-Aug-23 4:06 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 08-Aug-23Purchase 87,057$12.00$1,044,330.005%
1.9M to 1.99M
09-Aug-23 4:06 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 07-Aug-23Purchase 134,493$12.00$1,614,410.008%
1.77M to 1.9M
22-Mar-23 4:06 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 21-Mar-23Purchase 160,590$11.52$1,850,000.0010%
1.61M to 1.77M
01-Feb-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 31-Jan-23Purchase 2,232$11.40$25,444.40< 1%
1.61M to 1.61M
01-Feb-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 30-Jan-23Purchase 24,708$11.36$280,624.002%
1.58M to 1.61M
31-Jan-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 27-Jan-23Purchase 21,875$11.40$249,298.001%
1.56M to 1.58M
17-Jan-23 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 12-Jan-23Purchase 100,000$11.90$1,190,000.0010%
1.02M to 1.12M
09-Jan-23 4:06 PM
View: 
Radeljevic Ana
Director
Merrimack Pharmaceuticals, ... (MACK) 06-Jan-23Purchase 4,156$12.03$49,996.70100%
0 to 4.16K
04-Jan-23 4:05 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 03-Jan-23Purchase 30,632$11.33$347,159.002%
1.53M to 1.56M
04-Jan-23 4:06 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 03-Jan-23Purchase 5,300$11.24$59,563.50< 1%
1.01M to 1.02M
03-Jan-23 4:16 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 30-Dec-22Purchase 41,300$11.33$468,040.003%
1.49M to 1.53M
04-Jan-23 4:06 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 30-Dec-22Purchase 1,300$11.24$14,615.00< 1%
1.01M to 1.01M
03-Jan-23 4:16 PM
View: 
Andersen Eric
Director
Merrimack Pharmaceuticals, ... (MACK) 29-Dec-22Purchase 218,636$10.55$2,306,680.0017%
1.27M to 1.49M
15-Jul-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 13-Jul-22Purchase 3,095$5.89$18,226.80< 1%
751.01K to 754.11K
13-Jul-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 12-Jul-22Purchase 2,816$5.86$16,515.60< 1%
748.2K to 751.01K
13-Jul-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 11-Jul-22Purchase 700$5.97$4,181.59< 1%
747.5K to 748.2K
11-Jul-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 08-Jul-22Purchase 1,378$5.99$8,249.12< 1%
746.12K to 747.5K
11-Jul-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 07-Jul-22Purchase 1,100$5.99$6,586.03< 1%
745.02K to 746.12K
05-Jul-22 4:06 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 30-Jun-22Purchase 1,550$5.76$8,921.49< 1%
743.47K to 745.02K
27-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 24-Jun-22Purchase 1,000$5.99$5,990.00< 1%
742.47K to 743.47K
27-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 23-Jun-22Purchase 500$6.00$3,000.00< 1%
741.97K to 742.47K
21-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 17-Jun-22Purchase 900$5.97$5,372.28< 1%
1.75M to 1.75M
21-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 16-Jun-22Purchase 520$5.45$2,832.96< 1%
1.75M to 1.75M
16-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 15-Jun-22Purchase 2,900$5.37$15,561.10< 1%
1.75M to 1.75M
16-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 14-Jun-22Purchase 20,938$5.17$108,319.001%
1.73M to 1.75M
14-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 13-Jun-22Purchase 9,699$5.15$49,938.20< 1%
1.72M to 1.73M
14-Jun-22 4:05 PM
View: 
Levy Noah G.
Director
Merrimack Pharmaceuticals, ... (MACK) 10-Jun-22Purchase 6,386$4.92$31,423.00< 1%
1.71M to 1.72M
13-Jun-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 09-Jun-22Purchase 4,452$5.15$22,918.004%
126.65K to 131.1K
09-Jun-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 08-Jun-22Purchase 349$5.14$1,795.12< 1%
126.3K to 126.65K
09-Jun-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 07-Jun-22Purchase 300$5.05$1,515.00< 1%
126.0K to 126.3K
26-May-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 25-May-22Purchase 132$5.13$677.79< 1%
125.87K to 126.0K
26-May-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 24-May-22Purchase 2,323$5.09$11,816.902%
123.55K to 125.87K
23-May-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 19-May-22Purchase 512$5.04$2,581.91< 1%
123.04K to 123.55K
19-May-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 18-May-22Purchase 5,000$5.08$25,407.004%
118.04K to 123.04K
19-May-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 17-May-22Purchase 225$5.10$1,146.51< 1%
117.81K to 118.04K
16-May-22 10:00 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 13-May-22Purchase 3$4.90$14.70< 1%
117.81K to 117.81K
16-May-22 10:00 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 12-May-22Purchase 2,471$5.04$12,456.102%
115.34K to 117.81K
25-Apr-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 21-Apr-22Purchase 5,000$6.00$30,001.005%
110.34K to 115.34K
01-Apr-22 4:05 PM
View: 
Crocker Gary L
See Remarks
Director
Merrimack Pharmaceuticals, ... (MACK) 31-Mar-22Purchase 300$6.18$1,853.01< 1%
110.04K to 110.34K